This week I had a great conversation with Russ Peloquin, Managing Partner of LifeSci Catalyst Partners. We dive into Russ's unique journey from aspiring exterminator (yes, you read that right!) to leading life science entrepreneur, discussing his extensive experience in commercialization, mergers, and acquisitions. Russ shares invaluable insights on the importance of marketing, fundraising strategies for biotech startups, the phases of taking a company from idea to commercialization, and the critical steps toward securing regulatory approvals. We also touch on the intersection of genome sequencing, blockchain, and AI, exploring how this convergence is set to democratize and capitalize on personal DNA. Whether you're new to biotech or an industry veteran, this episode offers a wealth of knowledge and practical advice on navigating the complex landscape of life sciences and startups.

• Get Russ's recommended book! Freakonomics: A Rogue Economist Explores the Hidden Side of Everything
• Learn more about LifeSci Catalyst Partners!
• Connect with Russ on LinkedIn!

Connect with us!

Link In with Carina

Subscribe here:

• Apple
• Spotify
• Google Podcast
• RSS feed

Learn more about Recruitomics Consulting

Check out our reading list

Download our free startup resources guide to grow your biotech efficiently

If you're on the job market, visit the Collaboratory Career Hub

00:00 Introduction and Early Aspirations

02:04 Journey into Medical Sales

03:37 Marketing and Commercialization Insights

05:31 Navigating Early-Stage Startups

08:39 Fundraising Strategies for Biotech Startups

15:00 Acquisitions and Exits

22:39 The Intersection of Genome Sequencing, Blockchain, and AI

29:49 Future Goals and Recommendations

31:47 Closing Remarks and Contact Information

This week I chatted with Renee Williams, Founder and Managing Partner at Williams Biotech Consulting. Renee is a seasoned fractional Chief Business Officer (CBO) for small and growing biotechnology companies. Renee shares her career path, insights into helping biotech startups secure funding and navigate partnerships, and the importance of adaptable strategies in a constantly evolving market. From term sheet negotiation to pitch deck reframes, Renee offers valuable advice and lessons for small companies. We also dissect her engagement tactics during major conferences like JP Morgan and the essential factors for biotech success.

• Get Renee's recommended book! The 3-Minute Rule: Say Less to Get More from Any Pitch or Presentation
• Link In with Renee!

Connect with us!

Link In with Carina

Subscribe here:

• Apple
• Spotify
• Google Podcast
• RSS feed

Learn more about Recruitomics Consulting

Check out our reading list

Download our free startup resources guide to grow your biotech efficiently

If you're on the job market, visit the Collaboratory Career Hub

00:00 Introduction and Childhood Dreams

01:19 The Power of Dressing the Part

01:49 Career Path and Consulting Firm

03:20 Role of a Fractional CBO

04:03 Navigating Startup Challenges

06:07 Crafting Effective Pitch Decks

08:32 Big Pharma vs. Biotech Mentality

16:01 The Importance of a Strong Team in Biotech

16:20 Approaching Pharma and Corporate Venture Capital

17:20 Strategies for Biotech Companies to Gain Traction

18:24 Types of Biotech CEOs and Their Approaches

21:02 Navigating Conferences and Networking

27:09 Future Goals and Aspirations

28:59 Book Recommendations and Closing Thoughts

This week, I spoke with Natalie Nairn, co-founder and CEO of Cyclera Therapeutics. Natalie is also a Termeer Fellow, and listeners of this podcast know how much I love the Termeer Foundation. We discuss her transition from chemical engineering to biomedical applications. She describes her unexpected path into the fun and volatile startup space, which led to her founding Cyclera. Natalie explains the importance of focusing in biotech development, the promising applications of Cyclera's technology in CNS therapeutics, and the challenges and opportunities in the current funding landscape. She also highlights the value of the Termeer fellowship in her career, the contrast between Boston and Seattle's biotech scenes, and the essential aspects of leadership and team cohesion. Finally, Natalie discusses her future goals for Cyclera and offers valuable advice for aspiring biotech founders.

• Get Natalie's recommended book! The Book of Delights: Essays
• CYpHER: catalytic extracellular targeted protein degradation with high potency and durable effect | Nature Communications
• Connect with Natalie on LinkedIn!
• Learn more about Cyclera Therapeutics

Connect with us!

Link In with Carina

Subscribe here:

• Apple
• Spotify
• Google Podcast
• RSS feed

Learn more about Recruitomics Consulting

Check out our reading list

Download our free startup resources guide to grow your biotech efficiently

If you're on the job market, visit the Collaboratory Career Hub

00:00 Introduction and Early Aspirations

00:33 Journey into Biomedical Engineering

01:19 First Startup Experience

03:40 Founding Cyclera

05:02 Focus on CNS Therapeutics

13:35 Challenges and Strategies in Biotech

15:39 The Termeer Foundation Fellowship

21:26 Biotech Networks: Boston vs. Seattle

26:50 Future of Cyclera and Personalized Medicine

32:45 Conclusion and Final Thoughts

In this episode, I had an engaging conversation with Stacie Frye, co-founder and Chief Commercial Officer of StimulusBio, a life sciences commercialization and venture studio for biotech startups. We discussed how StimulusBio aids startups in operational and commercialization aspects, leveraging Stacie's unique journey across marketing, chemical engineering, and her experience with successful biotech exits. Experience from previous startups profoundly informs StimulusBio’s approach to helping startups transition from incubation to market. We explored the critical stages of startup growth, emphasizing the importance of marketing, storytelling, team building, and experience-based advice. Stacie also shared her insights into the emerging trends in the biotech industry, particularly in Houston's growing biotech ecosystem, and the importance of balancing innovation with practical business needs.

• Get Stacie's recommended book! Think Again: The Power of Knowing What You Don't Know
• Learn about StimulusBio
• Connect with Stacie on LinkedIn!

Connect with us!

Link In with Carina

Subscribe here:

• Apple
• Spotify
• Google Podcast
• RSS feed

Learn more about Recruitomics Consulting

Check out our reading list

Download our free startup resources guide to grow your biotech efficiently

If you're on the job market, visit the Collaboratory Career Hub

00:00 Introduction to Stacie Frye and StimulusBio

00:51 Stacie's Unique Career Path

01:56 Early Career and Transition to Bioengineering

03:32 Startup Experiences and Lessons Learned

08:46 Challenges in Transitioning from Incubator to Market

12:44 The Importance of Marketing and Team Building

32:17 Emerging Trends and Future Goals

37:09 Conclusion and Contact Information

This week, I had an insightful conversation with David Sans, PhD, FAARM, MBA, who heads healthcare investment banking at EF Hutton. We discussed the intricacies of different Public Offering strategies, including micro IPOs, which offer a unique avenue for biotech companies. David provides a deep perspective on the strategic implications of IPOs for biotech funding. He emphasized the importance of investor support and strategic banking partnerships, especially for micro IPOs. We also discussed the potential of AI in reshaping financial services and the future of outcome-based pricing models in investment. David's personal insights reveal the demanding yet rewarding nature of investment banking and highlight crucial aspects to consider for those pursuing a career in this field.

• Get David's recommended book: Barcelona, Catalonia: A View from the Inside
• Learn more about EF Hutton LLC!
• Link In with David!

Connect with us!

Link In with Carina

Subscribe here:

• Apple
• Spotify
• Google Podcast
• RSS feed

Learn more about Recruitomics Consulting

Check out our reading list

Download our free startup resources guide to grow your biotech efficiently

If you're on the job market, visit the Collaboratory Career Hub

00:00 Introduction to Biotech and Investment Banking

00:48 David Sands' Background and Career Journey

02:12 Transition from Biotech to Finance

04:53 Understanding Micro IPOs

06:37 Challenges and Strategies in Biotech IPOs

16:38 The Role of the FDA in Biotech IPOs

18:30 Understanding IPO Disparities

18:42 Key Factors for a Successful IPO

19:29 Aftermarket Support and Investor Relations

20:59 The Role of Long-Term Investors

21:34 Personal Investment Strategies

22:29 Innovations in Financial Services

24:40 Challenges for Biotech CEOs

26:32 Career Path in Investment Banking

28:50 Future of Financial Services and AI

33:37 Book Recommendations and Closing Thoughts

This week I had a great conversation with Iva Toudjarska, founder and CEO of Zeal Therapeutics. From earning a PhD in molecular biology to a solid scientific career at Alnylam, to working in venture capital, to selling a successful SaaS company, Iva’s career that’s set her up well to enjoy this new challenge – founding a baby biotech. Her expertise marries business development, venture capital, and company-building. Iva shared valuable advice for biotech founders on securing funding, making strategic decisions, and building effective partnerships. Tune in to hear her experiences, lessons learned, and her current work leading Zeal Therapeutics, a precision kidney RNA therapeutics company.

• Get Iva's favorite book! The Alchemist
• Link In with Iva!

Connect with us!

Link In with Carina

Subscribe here:

• Apple
• Spotify
• Google Podcast
• RSS feed

Learn more about Recruitomics Consulting

Check out our reading list

Download our free startup resources guide to grow your biotech efficiently

If you're on the job market, visit the Collaboratory Career Hub

00:00 - Intro to Iva Toudjarska's Career

00:48 - Career overview, Iva Toudjarska, Zeal Therapeutics

04:26 - Successful biotech strategies, industry insights

07:02 - Building successful partnerships, collaboration tips

12:15 - Angel investing, funding strategies, biotech financing

20:20 - Leveraging background, skills for biotech success

24:38 - Setbacks in biotech, lessons learned, resilience

27:20 - Bootstrapping a company, startup funding, entrepreneurship

28:23 - Support for Eva, mentorship, biotech advice

29:18 - Future goals, biotech vision, 10-year plan

30:45 - Current reading, professional development, industry literature

24:24 Lessons Learned and Future Goals

28:08 Conclusion and Final Thoughts

This week I had a fun conversation with Jason Cordeiro, Chief Operating and Innovation Officer at MassBio. We dissect MassBio's newly announced five-year strategic plan that includes a multi-pronged set of initiatives aimed at advancing the biotech industry. From supporting early-stage startups to advocating for policy changes and fostering talent development, Jason details the excellent resources available and in development. Whether you're based in Massachusetts or global, this session provides valuable information on how MassBio is working to catalyze innovation and growth in biotech, and how you can leverage these opportunities.

00:00 - Intro

01:24 - Jason Cordeiro, MassBio’s COO

02:48 - What is MassBio

05:54 - MassBio’s MassCONNECT Program

08:15 - MassCONNECT Support for Non-Local Companies

13:15 - How to Get Involved in MassBio

17:24 - Next Level One Initiative

19:58 - MassBio Align Summit Overview

21:40 - Educating Investors through MassBio

27:11 - MassBio Pharma Days Event

31:00 - The Link Program

34:54 - MassBio’s 5-Year Strategic Plan

41:14 - Connecting with MassBio Resources

42:11 - Outro

• Learn about Align Summit - MassBio
• Learn about Partnering Opportunities - MassBio
• Learn about the CEO & Founder Link - MassBio
• Learn about MassBio’s Vision 2030 strategic plan
• Learn about MassBioDrive!
• Learn about MassBio Innovation
• Learn more about Massachusetts Biotechnology Council
• Linked In with Jason!

Connect with us!

Link In with Carina

Subscribe here:

• Apple
• Spotify
• Google Podcast
• RSS feed

Learn more about Recruitomics Consulting

Check out our reading list

Download our free startup resources guide to grow your biotech efficiently

If you're on the job market, visit the Collaboratory Career Hub

In this episode, we revisit a fun conversation with Mike LaRhette, Chief Business Officer at LabCentral. Mike outlines the essentials for startups, including funding, lab space, mentorship, and resources. He shares his journey from aspiring architect to an architect of biotech ecosystems, detailing his experiences with MassChallenge and LabCentral. Mike offers insights into the key elements that make thriving ecosystems, like government support, industry collaboration, and a density of entrepreneurs. He also discusses how LabCentral supports startups through challenging markets, diverse talent acquisition, and successful graduations. The episode concludes with a lighthearted look at LabCentral's unique culture and the balance between hard work and fun.

• Learn about LabCentral
• Conttect: Michael LaRhette - LabCentral

Connect with us!

Link In with Carina

Subscribe here:

• Apple
• Spotify
• Google Podcast
• RSS feed

Learn more about Recruitomics Consulting

Check out our reading list

Download our free startup resources guide to grow your biotech efficiently

If you're on the job market, visit the Collaboratory Career Hub

00:00 Introduction and Episode Overview

00:49 Meet Mike LaRhette: From Architect Aspirations to Ecosystem Builder

01:59 Journey into the Biotech Sector

04:34 A Day in the Life at LabCentral

07:32 The Human Side of Biotech Entrepreneurship

09:55 LabCentral Ignite: Bridging Talent and Opportunity

12:08 Effective Communication Strategies at LabCentral

18:13 Key Elements of a Successful Ecosystem

24:30 Debunking Myths About Entrepreneurs

25:58 Challenges in Post-COVID Event Engagement

26:58 Navigating the Tight Market

28:35 Golden Tickets Program

30:40 Support for New Founders at LabCentral

33:16 Transitioning Out of LabCentral

36:22 Balancing Fun and Seriousness at LabCentral

40:00 Future Directions and Personal Growth

41:49 Favorite Books and Final Thoughts

This week I spoke with Bogdan Knezevic, founder of Kaleidoscope Bio, about optimizing biotech workflows and achieving milestones efficiently. Bogdan shared insights into how his platform helps companies manage research and development processes, reducing operational inefficiencies and saving time, resources, and money. He discussed the importance of setting clear goals, breaking down complex workflows, and avoiding shiny object syndrome (a common ailment among scientists). Bogdan also emphasized the value of keeping teams focused and aligned, leveraging automation, and integrating existing tools to minimize manual work. We explored how to empower teams, balance short-term and long-term goals, and pivot gracefully when needed. Additionally, Bogdan touched on the importance of understanding the true cost of operations and making strategic investments in tools that drive productivity.

• Exhalation: Stories
• Get Bogdan's recommended book! Stories of Your Life and Others
• Biotech inflection points framework resource:
• Biotech fundraising milestones resource
• Learn more about Kaleidoscope!
• Link In with Bogdan!

Connect with us!

Link In with Carina

Subscribe here:

• Apple
• Spotify
• Google Podcast
• RSS feed

Learn more about Recruitomics Consulting

Check out our reading list

Download our free startup resources guide to grow your biotech efficiently

If you're on the job market, visit the Collaboratory Career Hub

00:00 Introduction to Systems and Workflow

01:10 Meet Bogdan Knezevic: From Childhood Dreams to Biotech CEO

02:22 The Frustration and Vision Behind Kaleidoscope Bio

04:01 Use Cases and Value Propositions for Biotech Companies

07:50 Empowering Teams and Setting Priorities

11:38 Balancing Short-Term and Long-Term Goals

18:22 Reducing Operational Overhead and Streamlining Processes

31:07 Common Mistakes and Lessons for Biotech Leaders

36:19 Book Recommendations and Closing Thoughts

This week I spoke with Jon Hu, CEO and co-founder of Pepper Bio, about his journey from pharma consulting and venture capital to founding a tech-enabled biotech company. Pepper Bio created an AI and machine learning platform accelerating drug discovery for untreatable diseases. In addition to the platform, Pepper is currently navigating their asset for liver cancer into phase 2 clinical trials. Jon highlighted the differences between tech and biotech, emphasizing the importance of dreaming big and aligning vision with employees. He shared insights on the importance of hiring, learning to learn, and overcoming challenges in transitioning from tech-enabled discovery to drug development. We also discussed Pepper Bio's computational platform, long-term strategy, and their Series A fundraising to support their clinical trial efforts. Jon’s personal story of family health challenges driving his passion for biotech underscored the company's mission to transform patient care.

• Start with Why: How Great Leaders Inspire Everyone to Take Action
• Get Jon's recommended book! What Do You Do With an Idea? New York Times best seller
• Learn more about Pepper Bio
• Link In with Jon!

Connect with us!

Link In with Carina

Subscribe here:

• Apple
• Spotify
• Google Podcast
• RSS feed

Learn more about Recruitomics Consulting

Check out our reading list

Download our free startup resources guide to grow your biotech efficiently

If you're on the job market, visit the Collaboratory Career Hub

00:00 Introduction to John Hu and Pepper Bio

00:54 John's Early Aspirations and Career Path

02:27 Founding Pepper Bio and Its Mission

05:15 Tech vs. Biotech: Ambitions and Challenges

10:42 Project Optimist and Pepper's Role

11:53 Pepper's Computational Platform and Future Goals

16:14 Navigating the Biotech Industry and Hiring Strategies

33:35 Personal Motivations and Future Aspirations

36:03 Book Recommendations and Closing Remarks